High levels of neural stem cell marker nestin are associated with 1q21 gain and predict whorse reposnse to conventional and novel therapy in multiple myeloma

ŠVÁCHOVÁ, Hana, Fedor KRYUKOV, Elena Vladimirovna DEMENTYEVA, Lenka KUBICZKOVÁ, Sabina ŠEVČÍKOVÁ, Pavel NĚMEC, Henrieta GREŠLIKOVÁ, Lucie ŘÍHOVÁ, Lenka ZAHRADOVÁ and Roman HÁJEK. High levels of neural stem cell marker nestin are associated with 1q21 gain and predict whorse reposnse to conventional and novel therapy in multiple myeloma. In 17th Congress of the European Hematology Association, Amsterdam. 2012. ISSN 0390-6078.

Basic information

• Original name: High levels of neural stem cell marker nestin are associated with 1q21 gain and predict whorse reposnse to conventional and novel therapy in multiple myeloma
• Authors: ŠVÁCHOVÁ, Hana, Fedor KRYUKOV, Elena Vladimirovna DEMENTYEVA, Lenka KUBICZKOVÁ, Sabina ŠEVČÍKOVÁ, Pavel NĚMEC, Henrieta GREŠLIKOVÁ, Lucie ŘÍHOVÁ, Lenka ZAHRADOVÁ and Roman HÁJEK.
• Edition: 17th Congress of the European Hematology Association, Amsterdam, 2012.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30200 3.2 Clinical medicine
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 5.935
• Organization unit: Faculty of Medicine
• ISSN: 0390-6078
• Keywords in English: nestin; multiple myeloma; gain 1q21

Links

• GAP304/10/1395, research and development project: Name: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií

Investor: Czech Science Foundation

• MSM0021622434, plan (intention): Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií

Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies